Detalles de la búsqueda
1.
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma.
Blood
; 116(9): 1405-12, 2010 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20448107
2.
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study.
Eur J Haematol
; 88(6): 485-96, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22404182
3.
Legionnaires' disease from a cooling tower in a community outbreak in Lidköping, Sweden- epidemiological, environmental and microbiological investigation supported by meteorological modelling.
BMC Infect Dis
; 12: 313, 2012 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23171054
4.
Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.
Eur J Haematol
; 87(2): 117-22, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21535157
5.
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
Lancet Oncol
; 11(10): 973-82, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20863761
6.
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.
Haematologica
; 91(9): 1228-33, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16956822
7.
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Cancer
; 112(1): 129-35, 2008 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17973267
8.
Serum calcium is an independent predictor of quality of life in multiple myeloma.
Eur J Haematol
; 78(1): 29-34, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17038019
9.
A community outbreak of Legionnaires' disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures.
Scand J Infect Dis
; 39(3): 217-24, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17366051
10.
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
Br J Haematol
; 133(4): 389-96, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16643445
11.
Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.
Br J Haematol
; 128(5): 631-5, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15725084
12.
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.
Eur J Haematol
; 75(4): 293-8, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16146535
13.
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma.
Br J Haematol
; 125(2): 149-55, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15059136
14.
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
Br J Haematol
; 120(6): 1037-46, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12648074
Resultados
1 -
14
de 14
1
Próxima >
>>